Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro - Mizuochi, Y; Okajima, K; Harada, N (Transl Res, 2007)
et al.